Anakinra
- SubcutAnakinraKineret
Mechanism of Action
- Interleukin-1 receptor antagonist (IL1-RA) is a naturally occurring protein that inhibits the binding of IL-1 to its receptor. Anakinra is human recombinant IL-1RA that competitively inhibits IL-1 binding, resulting in reduced acute phase response.
Clinical Use
- Indications
- Cryopyrin-associated periodic syndromes (CAPS) in adults and children 2 years or older
- Systemic juvenile idiopathic arthritis refractory to non-biologic DMARDs
- Rheumatoid arthritis refractory to one or more other DMARDs
- Contraindications
- Concurrent treatment with TNF-alpha inhibitors
- Neutropaenia
- Adverse Effects
- Hypersensitivity reactions
- Infections
- Neutropaenia
- Thrombocytopaenia
- Headache
- Nausea / vomiting / diarrhoea
- LFT derangement
- Hypercholesterolaemia